The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 13.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it strong buy, with a mean price target of $63. Insiders have been net sellers over the past quarter.
Bank of America BAC
Outside both standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Bank of America Corporation, through its subsidiaries, provides various financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and gover…
read at $63.25
Bank of America holds its Accumulation at $63.25.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 18 days |
| Price | $63.25 |
| Valuation | 14.61 trailing · 11.96 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.17 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 17% discount to our $73.91 fair value, moderate competitive moat, 16.80% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 16.80% |
| Profit margin | 29.52% |
| Analyst consensus | Buy · 22 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity: Financials sector Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Familiar Bank Name Fails Ethical Screen
Bank of America moves money for millions of households and firms every day, yet that everyday reach hides the real issue. Revenue growth sits at 21 percent with 30 percent profit margins and an 11 percent return on equity, yet none of it matters once the business activity screen is failed.
We pass for that single reason. The 11.7 times forward earnings and 19 percent gap to fair value look tempting on paper, and the moderate moat plus buy-rated analyst targets add to the surface appeal. The ethical verdict overrides all of it.
Cyclical banks can appear cheap on low multiples right before earnings turn, and this one carries the same trap. Analysis, not advice.
| Forward P/E | 12.0x cheap for a company growing this fast |
| Trailing P/E | 14.6x reasonably valued |
| Revenue growth | 16.8% steady growth |
| Profit margin | 29.5% healthy profit margins |
| Return on equity | 11.2% a modest return on shareholder capital |
| Beta | 1.17 moves a little more than the market |
| Market cap | $442.3B |
| Employees | 212,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on BAC
- › Broadcom Sinks 6% as BofA Flags $370B in AI Debt, AMD Climbs 4% on Baird’s $1,250 Call 24/7 Wall St. · 1d ago
- › BofA biotech scorecard: Two buys and odd one out TheStreet · 2d ago
- › Is Citigroup a Solid Investment Option After a 51.2% Jump in a Year? Zacks · 2d ago
- › The AI build-out has a problem that $1 trillion in cash can't fix Yahoo Finance · 2d ago
- › Bank of America’s Top Pick for a $210B Market Is AMD, But Traders Prefer This Other Stock BeInCrypto · 2d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in BAC's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
BAC trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 24%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (22 analysts) rates it strong buy, with a mean price target of $63. Insiders have been net sellers over the past quarter.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-05 | Greener Geoffrey S | Chief Risk Officer | Sale | 126,756 | $6,718,702,000 |
| 2026-03-12 | Mensah Bernard A | Pres, International | Sale | 94,000 | $4,412,642,000 |
| 2026-03-05 | Scrivener Thomas M | Chief Operations Exec | Sale | 50,000 | $2,491,000,000 |
| 2026-03-04 | Demare James P | Co-Pres | Sale | 83,832 | $4,191,600,000 |
| 2026-03-05 | Bronstein Sheri B. | Chief People Officer | Sale | 60,000 | $2,994,600,000 |
| 2026-03-03 | Athanasia Dean C | Co-Pres | Sale | 136,558 | $6,856,168,000 |
| 2026-02-27 | Borthwick Alastair M | EVP, CFO | Sale | 68,000 | $3,416,320,000 |
| 2025-08-01 | Demare James P | Pres, Global Markets | Sale | 148,391 | $6,761,733,000 |
| 2026-05-15 | MOYNIHAN BRIAN T | Chief Executive Officer | 18,083 | · | |
| 2026-05-05 | GREENER GEOFFREY S | Officer | 126,756 | $6,718,702 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 Feb2025 | Tim Walberg | Republican | buy | 15K–50K |
| 30 Mar2026 | Alan Armstrong | Republican | buy | 15K–50K |
| 27 May2026 | John Boozman | Republican | buy | 1K–15K |
| 2026-04-24 | Ro Khanna | Democrat | Purchase | 15K–50K |
| 2026-04-13 | Ro Khanna | Democrat | Sale | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $50.29 | +9.0% | $0.28 | $1,096 | +9.6% |
| 2 months | $52.27 | +4.9% | $0.28 | $1,054 | +5.4% |
| 3 months | $46.89 | +16.9% | $0.28 | $1,175 | +17.5% |
| 6 months | $53.97 | +1.6% | $0.56 | $1,026 | +2.6% |
| 1 year | $44.13 | +24.2% | $1.12 | $1,268 | +26.8% |
| 2 years | $37.90 | +44.7% | $2.16 | $1,504 | +50.4% |
| 3 years | $27.15 | +101.9% | $3.12 | $2,134 | +113.4% |
| 5 years | $37.04 | +48.0% | $4.84 | $1,611 | +61.1% |
Historical returns from market close data. Past performance does not guarantee future results.